These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Does early detection lead to an improved prognosis in cystic fibrosis neonates? Chatfield S; Owen G; Ryley H; Goodchild M; Weller P Acta Univ Carol Med (Praha); 1990; 36(1-4):96-8. PubMed ID: 2130733 [No Abstract] [Full Text] [Related]
25. Clinical trials in infants with cystic fibrosis detected following newborn screening. Stick SM Paediatr Respir Rev; 2008 Sep; 9(3):176-80. PubMed ID: 18694709 [TBL] [Abstract][Full Text] [Related]
26. Newborn screening showing decreasing incidence of cystic fibrosis. Hale JE; Parad RB; Comeau AM N Engl J Med; 2008 Feb; 358(9):973-4. PubMed ID: 18305279 [No Abstract] [Full Text] [Related]
27. Policy issues for expanding newborn screening programs: the cystic fibrosis newborn screening experience in the United States. Wilfond BS; Gollust SE J Pediatr; 2005 May; 146(5):668-74. PubMed ID: 15870672 [TBL] [Abstract][Full Text] [Related]
28. Cystic fibrosis in neonates and infants. Minasian C; McCullagh A; Bush A Early Hum Dev; 2005 Dec; 81(12):997-1004. PubMed ID: 16278058 [TBL] [Abstract][Full Text] [Related]
29. [Neonatal screening for cystic fibrosis : towards a national implementation in Belgium in 2019]. Boboli H; Boemer F; Mastouri M; Seghaye MC Rev Med Liege; 2018 Oct; 73(10):497-501. PubMed ID: 30335254 [TBL] [Abstract][Full Text] [Related]
30. Outcomes of infants with indeterminate diagnosis detected by cystic fibrosis newborn screening. Ren CL; Fink AK; Petren K; Borowitz DS; McColley SA; Sanders DB; Rosenfeld M; Marshall BC Pediatrics; 2015 Jun; 135(6):e1386-92. PubMed ID: 25963008 [TBL] [Abstract][Full Text] [Related]
35. Edema and hypoproteinemia in infants with cystic fibrosis. The hypoalbuminemia sometimes seen is presumably secondary to malabsorption. Dolan TF; Rowe DS; Gibson LE Clin Pediatr (Phila); 1970 May; 9(5):295-7. PubMed ID: 5445070 [No Abstract] [Full Text] [Related]
36. Ethical issues in cystic fibrosis newborn screening: from data to public health policy. Wilfond B; Rothenberg LS Curr Opin Pulm Med; 2002 Nov; 8(6):529-34. PubMed ID: 12394162 [TBL] [Abstract][Full Text] [Related]
37. Policy issues related to expanded newborn screening: a review of three genetic/metabolic disorders. Bishop Hubbard H Policy Polit Nurs Pract; 2007 Aug; 8(3):201-9. PubMed ID: 18178927 [TBL] [Abstract][Full Text] [Related]
38. Neonatal screening for cystic fibrosis in the Trent region (UK): two-stage immunoreactive trypsin screening compared with a three-stage protocol with DNA analysis as an intermediate step. Pollitt RJ; Dalton A; Evans S; Hughes HN; Curtis D J Med Screen; 1997; 4(1):23-8. PubMed ID: 9200059 [TBL] [Abstract][Full Text] [Related]
39. Newborn screening for cystic fibrosis. Wallace J; Stein Q S D Med; 2006 Oct; 59(10):429-31. PubMed ID: 17124920 [No Abstract] [Full Text] [Related]
40. Clinical outcomes in infants with cystic fibrosis transmembrane conductance regulator (CFTR) related metabolic syndrome. Ren CL; Desai H; Platt M; Dixon M Pediatr Pulmonol; 2011 Nov; 46(11):1079-84. PubMed ID: 21538969 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]